Giraudo Bryan Insider Trading Activity

Average Profitability
121.93%
Insider Buys Quantity
11
Insider Buys Sum
$825,312.95
Insider Sells Quantity
3
Insider Sells Sum
$155,062.89

Insider Activity of Giraudo Bryan

According to the SEC Form 4 filings, Giraudo Bryan, being in a position of

  1. director at Protagonist Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 59130 shares for $5.92M,
    over all time since 2017-05-16, has bought 26000 shares for $155,806, and sold 59130 shares for $5.92M.

Biography of Giraudo Bryan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,918,8802100

Comparison of Insiders on Amount of Buys and Sells

2026-05-08SaleProtagonist Therapeutics, Inc.
PTGX
director
11,130
0.0174%
$100.00$1.11M+38.97%
2026-05-07SaleProtagonist Therapeutics, Inc.
PTGX
director
48,000
0.0756%
$100.12$4.81M+39.64%
2024-06-18PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
100,000
0.0512%
$0.59$59,110+77.24%
2024-03-27SaleGossamer Bio, Inc.
GOSS
COO/CFO
6,430
0.0028%
$1.16$7,431-22.01%
2023-11-13PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
200,000
0.0795%
$0.56$112,880+42.98%
2023-04-04PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
55,000
0.0583%
$1.02$56,095+3.96%
2022-07-15PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
13,869
0.0099%
$7.21$99,995-79.92%
2022-03-23SaleGossamer Bio, Inc.
GOSS
COO/CFO
10,722
0.0143%
$8.91$95,587-4.09%
2021-03-23SaleGossamer Bio, Inc.
GOSS
Chief Financial Officer
5,490
0.0077%
$9.48$52,046+1.54%
2020-10-14PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
6,000
0.0094%
$10.01$60,072-1.02%
2020-06-23PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
4,000
0.0061%
$12.96$51,845-21.51%
2019-12-03PurchaseProtagonist Therapeutics, Inc.
PTGX
director
16,000
0.0705%
$5.70$91,240+243.28%
2019-09-26PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
2,242
0.0019%
$8.39$18,810-14.76%
2019-05-30PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
2,000
0.0017%
$9.35$18,700-11.88%
2019-02-12PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
12,000
0.0286%
$16.00$192,000+6.27%
2017-05-16PurchaseProtagonist Therapeutics, Inc.
PTGX
director
10,000
0.0357%
$6.46$64,566+46.97%
Total: 16
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.